Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. (CDIO) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CDIO · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Cardio Diagnostics Holdings, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
CDIO insider buying and selling by quarter
CDIO insider selling · CDIO insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
CDIO executive sell shares · CDIO board member insider trading · CDIO insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 6, 2024 | Philibert Robert Chief Medical Officer · Director | Purchase | 7,460 | $2K | Form 4 |
| Sep 6, 2024 | Philibert Robert Chief Medical Officer · Director | Purchase | 26,615 | $8K | Form 4 |
| Sep 6, 2024 | Dogan Meeshanthini CTO | Purchase | 68,965 | $20K | Form 4 |
| Sep 6, 2024 | Dogan Meeshanthini CEO · Director | Purchase | 68,965 | $20K | Form 4 |
| Mar 31, 2024 | Burton Paul Frederick Director | Option | 8,803 | $13K | Form 4 |
| Mar 31, 2024 | Lau Stanley K. Director | Option | 8,803 | $13K | Form 4 |
| Mar 31, 2024 | Intrater James Director | Option | 8,803 | $13K | Form 4 |
| Mar 31, 2024 | Levy Oded Director | Option | 8,803 | $13K | Form 4 |
| Jan 31, 2024 | Lau Stanley K. Director | Option | 917 | $2K | Form 4 |
| Dec 31, 2023 | Sim Brandon Director | Option | 5,020 | $12K | Form 4 |
| Dec 31, 2023 | Intrater James Director | Option | 5,020 | $12K | Form 4 |
| Dec 31, 2023 | Lau Stanley K. Director | Option | 5,020 | $12K | Form 4 |
| Dec 31, 2023 | Lau Stanley K. Director | Option | 1,606 | $4K | Form 4 |
| Oct 31, 2023 | Lau Stanley K. Director | Option | 6,631 | $2K | Form 4 |
| Sep 30, 2023 | Lau Stanley K. Director | Option | 36,765 | $13K | Form 4 |
| Sep 30, 2023 | Lau Stanley K. Director | Option | 5,882 | $2K | Form 4 |
| Aug 31, 2023 | Lau Stanley K. Director | Option | 3,637 | $2K | Form 4 |
| Jul 31, 2023 | Lau Stanley K. Director | Option | 1,653 | $2K | Form 4 |
| Aug 31, 2023 | Dogan Meeshanthini CEO · Director | Purchase | 16,481 | $9K | Form 4 |
| Aug 25, 2023 | Dogan Meeshanthini CEO · Director | Purchase | 1,770 | $982 | Form 4 |
| Aug 31, 2023 | Dogan Timur CTO | Purchase | 16,481 | $9K | Form 4 |
| Aug 25, 2023 | Dogan Timur CTO | Purchase | 1,770 | $982 | Form 4 |
| Aug 28, 2023 | Philibert Robert Chief Medical Officer · Director | Purchase | 100 | $57 | Form 4 |
| Aug 28, 2023 | Philibert Robert Chief Medical Officer · Director | Purchase | 17,900 | $11K | Form 4 |
| Aug 24, 2023 | Philibert Robert Chief Medical Officer · Director | Purchase | 16,000 | $10K | Form 4 |
Philibert Robert
Chief Medical Officer · Director
Date
Sep 6
Shares
7,460
Price
$0.28
Value
$2K
Philibert Robert
Chief Medical Officer · Director
Date
Sep 6
Shares
26,615
Price
$0.29
Value
$8K
Dogan Meeshanthini
CEO · Director
Date
Sep 6
Shares
68,965
Price
$0.29
Value
$20K
Dogan Meeshanthini
CEO · Director
Date
Aug 31
Shares
16,481
Price
$0.55
Value
$9K
Dogan Meeshanthini
CEO · Director
Date
Aug 25
Shares
1,770
Price
$0.56
Value
$982
Philibert Robert
Chief Medical Officer · Director
Date
Aug 28
Shares
100
Price
$0.57
Value
$57
Philibert Robert
Chief Medical Officer · Director
Date
Aug 28
Shares
17,900
Price
$0.60
Value
$11K
Philibert Robert
Chief Medical Officer · Director
Date
Aug 24
Shares
16,000
Price
$0.60
Value
$10K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CDIO insider trading
CDIO insider trades
Cardio Diagnostics Holdings, Inc. (CDIO) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including CDIO. Over the past 12 months, 0 insiders have filed transactions with the SEC. CDIO insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Cardio Diagnostics Holdings, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CDIO insider trading · 5 questionsThe insiders of Cardio Diagnostics Holdings, Inc. (CDIO) include executives and directors such as CDIO, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026